Peter J. Graham
General Counsel bei ADC THERAPEUTICS SA
Ursprung des Netzwerks ersten Grades von Peter J. Graham
| Einheit | Art der Einheit | Industrie | |
|---|---|---|---|
| Subsidiary | Pharmaceuticals: Major | 29 | |
| Public Company | Pharmaceuticals: Major | 24 | |
| Public Company | Medical Specialties | 23 | |
Benjamin N. Cardozo School of Law
12
| College/University | Other Consumer Services | 12 |
| Public Company | Medical Specialties | 12 | |
E-Z-EM, Inc.
 E-Z-EM, Inc. Medical SpecialtiesHealth Technology E-Z-EM, Inc. develops, manufactures and markets diagnostic imaging products. The firm's products are used for computed tomography and magnetic resonance imaging, colorectal cancer screening, evaluation of swallowing disorders and testing for other diseases, and disorders of the gastrointestinal system. The company was founded in 1961 and is headquartered in Lake Success, NY.
11
| Subsidiary | Medical Specialties | 11 |
ACIST Medical Systems, Inc.
 ACIST Medical Systems, Inc. Medical SpecialtiesHealth Technology ACIST Medical Systems, Inc. provides technology for contrast imaging system in the fields of cardiology and radiology. The company was founded by Robert F. Wilson in 1991 and is located in Eden Prairie, MN.
1
| Subsidiary | Medical Specialties | 1 |
Unternehmensgrafik - zweiten Grades
Beziehungen zu mehreren Unternehmen
Unternehmensverbindungen über das persönliche Netzwerk von Peter J. Graham
| Unternehmen | Sektor | Verknüpfte Personen | Hauptposition |
|---|---|---|---|
| University of Michigan | College/University | Undergraduate Degree Doctorate Degree Undergraduate Degree Undergraduate Degree Undergraduate Degree | |
| AUXILIUM PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Director/Board Member Human Resources Officer Director of Finance/CFO Sales & Marketing Chief Tech/Sci/R&D Officer | |
| The Trustees of Columbia University in The City of New York | College/University | Undergraduate Degree Chairman Doctorate Degree Doctorate Degree Undergraduate Degree | |
| Massachusetts Institute of Technology | College/University | Chief Tech/Sci/R&D Officer Graduate Degree Undergraduate Degree Undergraduate Degree | |
| AMGEN INC. | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal | |
| HALOZYME THERAPEUTICS, INC. | Biotechnology | Chief Executive Officer Investor Relations Contact Director/Board Member Director of Finance/CFO | |
| The Wharton School of the University of Pennsylvania | College/University | Masters Business Admin Undergraduate Degree Masters Business Admin Masters Business Admin | |
| BRISTOL-MYERS SQUIBB COMPANY | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal | |
| ARRAY TECHNOLOGIES, INC. | Pharmaceuticals: Major | Chief Executive Officer Chief Tech/Sci/R&D Officer Human Resources Officer | |
| NOVARTIS AG | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal Director of Finance/CFO | |
| CELATOR PHARMACEUTICALS INC | Pharmaceuticals: Major | Director of Finance/CFO Director/Board Member Director/Board Member | |
| North American Instrument Corp. | Miscellaneous | Corporate Officer/Principal Sales & Marketing Sales & Marketing | |
| ELI LILLY AND COMPANY | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal | |
Syncromune, Inc.
 Syncromune, Inc. Pharmaceuticals: MajorHealth Technology Syncromune, Inc. is a clinical-stage biopharmaceutical company that is dedicated to developing an in situ platform technology optimized for metastatic solid tumor cancers. The company is based in Fort Lauderdale, FL. The company is currently developing Sync-T™, a novel combination drug/device treatment platform that aims to achieve high response rates with potentially curative efficacy. The therapy is designed to synchronize in situ neoantigen T cell education and immunostimulation via intratumoral/locoregional infusion, with the goal of enabling the immune system to recognize and attack cancer throughout the body. The first two candidates, SV-101 and SV-102, are currently in investigator-initiated phase 1 trials. Link. The company was founded in 2020 by Charles J. Eamonn P. Hobbs has been the CEO of the company since 2020. | Pharmaceuticals: Major | Corporate Officer/Principal Director/Board Member Chief Executive Officer | |
| Lehigh University | College/University | Undergraduate Degree Undergraduate Degree Undergraduate Degree | |
ImmunSYS, Inc.
 ImmunSYS, Inc. Pharmaceuticals: MajorHealth Technology ImmunSYS, Inc. is a clinical stage biopharmaceutical company focused on the development of cancer immunotherapy products. The company was founded by Eamonn P. Hobbs and Charles J. Link Jr. in March 2018 and is headquartered in Fort Lauderdale, FL. | Pharmaceuticals: Major | Corporate Officer/Principal Director/Board Member Founder | |
| CELGENE | Biotechnology | Corporate Officer/Principal Comptroller/Controller/Auditor Corporate Officer/Principal | |
Schering-Plough Corp.
 Schering-Plough Corp. Pharmaceuticals: MajorHealth Technology Schering Plough Corp. manufactures and sells pharmaceuticals, consumer and animal health care products. The firm discovers, develops, manufactures and markets advanced drug therapies. The company is headquartered in Kenilworth, NJ. | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal | |
ADC Products (UK) Ltd.
 ADC Products (UK) Ltd. Medical/Nursing ServicesHealth Services ADC Products (UK) Ltd. operates as a clinical stage biotechnology company. It develops pyrrolobenzodiazepines for antibody-drug conjugation. The company was founded in November 2000 and is headquartered in Reading, the United Kingdom. | Medical/Nursing Services | Founder Director/Board Member Director/Board Member | |
Access Closure, Inc.
 Access Closure, Inc. Medical SpecialtiesHealth Technology Access Closure, Inc. manufactures and distributes medical devices for cardiovascular and peripheral vascular markets. Its products include Mynx ace, Mynx grip, Mynx sealant technology and flash ostial system. The company was in founded in 2002 by Farhad Khosravi and is headquartered in Santa Clara, CA. | Medical Specialties | Chief Executive Officer Director/Board Member | |
Novartis Oncology, Inc.
 Novartis Oncology, Inc. Pharmaceuticals: MajorHealth Technology Novartis Oncology, Inc. provides healthcare solutions. The firm offers medicines, eye care and generic pharmaceuticals. It also offers patient declaration, patient support and assistance, and additional resources. The company is headquartered in East Hanover, NJ. | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal | |
Veniti, Inc.
 Veniti, Inc. Medical SpecialtiesHealth Technology Veniti, Inc. operates as a medical device company which focuses on the treatment of venous insufficiency. Its products include VENI RF Plus which uses radio frequency generated steam to destroy problematic veins that manifest as varicose veins; VENI Vena Cava Filter system which is engineered to improve the accuracy, efficiency of deployment, placement and retrieval; and VICI Venous Stent which is designed specifically for the treatment of venous outflow obstruction. The company was founded by Sean C. Morris and Mark Klopp in 2009 and is headquartered in Fremont, CA. | Medical Specialties | Chief Tech/Sci/R&D Officer Founder | |
| SUCAMPO PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Chief Executive Officer Director/Board Member | |
Cook, Inc.
 Cook, Inc. Medical DistributorsDistribution Services Cook, Inc. develops healthcare devices. The company integrates minimally invasive medical device design, biopharma, gene and cell therapy, and biotech to enhance patient safety as well as improve clinical outcomes in the fields of aortic intervention, interventional cardiology, critical care medicine, gastroenterology, radiology, peripheral vascular, bone access & oncology, surgery and soft tissue repair, urology, and assisted reproductive technology, gynecology as well as high-risk obstetrics. The company is located in Bloomington, IN. | Medical Distributors | Sales & Marketing Corporate Officer/Principal | |
MedImmune Ventures, Inc.
 MedImmune Ventures, Inc. Investment ManagersFinance MedImmune Ventures, Inc. ( Medimmune Ventures) is a venture capital firm founded in 2002 by Ron Laufer, Wayne Hockmeyer and David Mott . The firm is headquartered in Gaithersburg, Maryland. | Investment Managers | President Corporate Officer/Principal | |
Auven Therapeutics Management LLLP
 Auven Therapeutics Management LLLP Investment ManagersFinance Founded in 2007 by Stephen Evans-Freke and Peter Corr, Auven Therapeutics Management LLLP is a global private equity firm located in St. Thomas, Virgin Islands. They also have operations in New York City and Europe. The firm was formerly known as Celtic Therapeutics Management, which was the successor firm to Celtic Pharma Management LP. | Investment Managers | Founder Private Equity Investor | |
| The State University of New York | College/University | Masters Business Admin Masters Business Admin | |
| The Curtis L. Carlson School of Management | College/University | Undergraduate Degree Masters Business Admin | |
| HOSPIRA, INC. | Pharmaceuticals: Major | Corporate Officer/Principal Human Resources Officer | |
| Aventis Behring LLC | Public Communications Contact Director of Finance/CFO | ||
Genentech, Inc.
 Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Biotechnology | Corporate Officer/Principal Corporate Officer/Principal | |
| University of Cambridge | College/University | Corporate Officer/Principal Graduate Degree | |
Lakewood-Amedex, Inc.
 Lakewood-Amedex, Inc. Pharmaceuticals: MajorHealth Technology Lakewood-Amedex, Inc. engages in the development of treatment for serious infectious diseases. Its product pipeline include Nu-3 cDFU, Nu-3 Oral Mucositis, Nu-8 cUTI, and Nu-8 (Cystic Fibrosis). The company is headquartered in Sarasota, FL. | Pharmaceuticals: Major | Chairman Director/Board Member | |
| IMMUNOGEN, INC. | Biotechnology | Corporate Officer/Principal Corporate Officer/Principal | |
ADC Therapeutics (UK) Ltd.
 ADC Therapeutics (UK) Ltd. BiotechnologyHealth Technology Part of ADC Therapeutics SA, ADC Therapeutics (UK) Ltd. is a British company that provides research and experimental development in biotechnology. The company is based in Reading, UK and was founded in 2014. | Biotechnology | Director/Board Member Director/Board Member | |
| The Leonard N Stern School of Business | College/University | Masters Business Admin Masters Business Admin | |
American Liver Foundation
 American Liver Foundation Miscellaneous Commercial ServicesCommercial Services American Liver Foundation engages in facilitating, advocating and promoting education, support, and research for the prevention, treatment, and cure of liver disease. It educates patients, policymakers and the public and provides grants to early-career researchers to help find a cure for all liver diseases. The company was founded in 1976 and is headquartered in New York, NY. | Miscellaneous Commercial Services | Corporate Officer/Principal Director/Board Member | |
| The University of Chicago | College/University | Masters Business Admin Undergraduate Degree | |
Auven Therapeutics Holdings LP
 Auven Therapeutics Holdings LP Investment ManagersFinance Auven Therapeutics Holdings LP invests in late stage companies developing therapeutic products (small-molecules & biologics) and related diagnostics. It provides financing for buyouts and late stage capital requirements. It makes controlling investments. | Investment Managers | Founder Chief Executive Officer | |
| AURINIA PHARMACEUTICALS INC. | Biotechnology | Chief Executive Officer Director/Board Member | |
| Tufts University | College/University | Undergraduate Degree Undergraduate Degree | |
| The Pennsylvania State University | College/University | Undergraduate Degree Undergraduate Degree | |
| DUN & BRADSTREET CORP | Data Processing Services | Director of Finance/CFO Human Resources Officer | |
| University of Pennsylvania | College/University | Undergraduate Degree Doctorate Degree | |
| Kellogg School of Management | College/University | Masters Business Admin Masters Business Admin | |
| MGT CAPITAL INVESTMENTS, INC. | Information Technology Services | Chief Executive Officer Chairman |
Statistik
International
| Vereinigte Staaten | 43 |
| Vereinigtes Königreich | 5 |
| Schweiz | 2 |
| Kanada | 2 |
Sektoral
| Health Technology | 25 |
| Consumer Services | 14 |
| Finance | 5 |
| Technology Services | 4 |
| Health Services | 3 |
Operativ
| Director/Board Member | 463 |
| Corporate Officer/Principal | 223 |
| Independent Dir/Board Member | 143 |
| President | 87 |
| Chief Executive Officer | 85 |
Am stärksten vernetzte Beziehungen
| Insiders | |
|---|---|
| Dennis Langer | 40 |
| Stephen Evans-Freke | 34 |
| William Dodge Rueckert | 31 |
| Peter Greenleaf | 31 |
| Douglas G. Watson | 30 |
| Karen Smith | 29 |
| Marvin Samson | 28 |
| Laura Brege | 27 |
| John Preston | 27 |
| Jean Bizzari | 24 |
| Eamonn Hobbs | 23 |
| Jacques Theurillat | 22 |
| Viviane Monges | 21 |
| Gregory David Casciaro | 20 |
| Michael Forer | 18 |
- Börse
- Insiders
- Peter J. Graham
- Unternehmensverbindungen
